Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip. Issue 12 (December 2015)

• Record Type: Journal Article
• Authors: Lind, Lars; Siegbahn, Agneta; Lindahl, Bertil; Stenemo, Markus; Sundström, Johan; Ärnlöv, Johan
• Is Part Of: Stroke. Volume 46:Issue 12(2015)
• Publication Date: 2015-12
• Subjects: adrenomedullin -- natriuretic peptide, brain -- proteins -- risk factors -- stroke; Cerebrovascular disease -- Periodicals; Cerebral circulation -- Periodicals; 616.81
• DOI: 10.1161/STROKEAHA.115.010829
• Languages: English
• ISSNs: 0039-2499

Abstract

Abstract : Background and Purpose—: Emerging technologies have made it possible to simultaneously evaluate a large number of circulating proteins as potential new stroke risk markers. Methods—: We explored associations between 85 cardiovascular proteins, assessed by a proteomics chip, and incident ischemic stroke in 2 independent cohorts of elderly (Prospective Investigation of the Vasculature in Uppsala Seniors [PIVUS]: n=977; 50% women, mean age=70.1 years, 71 fatal/nonfatal ischemic stroke events during 10.0 years; and Uppsala Longitudinal Study in Adult Men [ULSAM]: n=720, mean age=77.5 years, 75 ischemic stroke events during 9.5 years). The proteomics chip uses 2 antibodies for each protein and a polymerase chain reaction step to achieve a high-specific binding and the possibility to measure multiple proteins in parallel, but gives no absolute concentrations. Results—: In PIVUS, 16 proteins were related to incident ischemic stroke using a false discovery rate of 5%. Of these, N-terminal pro-B-type natriuretic peptide ( P =0.0032), adrenomedullin ( P =0.018), and eosinophil cationic protein ( P =0.0071) were replicated in ULSAM after adjustment for established stroke risk factors. In predefined secondary meta-analyses of individual data, interleukin-27 subunit α, growth/differentiation factor 15, urokinase plasminogen activator surface receptor, tumor necrosis factor receptor superfamily member 6, macrophage colony-stimulating factor 1, and matrix metalloproteinase-7 were also potential risk markers for ischemic stroke after adjustment for multiple comparisons ( P <0.0006). The addition of N-terminal pro-B-type natriuretic peptide, adrenomedullin, and eosinophil cationic protein to a model with established risk factors increased the C-statistic from 0.629 to 0.689 ( P =0.001). Conclusions—: Our data suggest that large-scale proteomics analysis is a promising way of discovering novel biomarkers that could substantially improve the prediction of ischemic stroke. Abstract : Supplemental Digital Content is available in the text.